Paris, Ile-de-France, France Innoven Partners appeared to be the VC, which was created in 1998. The company was established in Europe in France. The main department of described VC is located in the Paris.
Among the most popular portfolio startups of the fund, we may highlight BioVex, EyeGate Pharmaceuticals, NAVX. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - France. Among the most popular fund investment industries, there are Biotechnology, Pharmaceutical. The fund has exact preference in some founders of portfolio startups.
Speaking about the real fund results, this VC is 4 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2015. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2004. This Innoven Partners works on 3 percentage points more the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Innoven Partners, startups are often financed by West Deutsche Landesbank Girozentrale, Ventech, Technomark Medical Ventures. The meaningful sponsors for the fund in investment in the same round are Ventech, Omnes Capital, Medicis Capital. In the next rounds fund is usually obtained by Ventech, Scottish Equity Partners, Omnes Capital.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Berlin.de | Berlin, Berlin, Germany |
| born2global | Kyonggi-do, Pangyo, South Korea |
| Centec Networks | China, Jiangsu, Suzhou |
| Chuchuang Investment | China, Shanghai |
| Fremont Ventures | California, San Francisco, United States |
| Fresenius Medical Care | Bad Homburg, Germany, Hessen |
| GTP Holdings | Australia, Launceston, Tasmania |
| i5invest | Austria, Vienna |
| Indo-US Venture Partners | California, Santa Clara, United States |
| KRW Schindler | Luxembourg, Luxembourg |
| Muhua Jinxin Investment Management | - |
| Pendyne Capital | - |
| Sympasis Innovation Capital | Baden-Wurttemberg, Ettlingen, Germany |
| Technology 9 Labs (T9L) | Delhi, India, New Delhi |
| Verissimo Ventures | - |
| Verus International | New York, New York, United States |
| Whitewater CDA | United States, Whitewater, Wisconsin |
| Yuanxi Capital | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
SpineGuard | $4M | 27 Sep 2011 | Ile-de-France | ||
Club Cooee | 27 Oct 2010 | Rhineland-Palatinate | |||
SpineGuard | $12M | 15 Sep 2009 | France, Ile-de-France, France | ||
EyeGate Pharmaceuticals | $15M | 12 Mar 2008 | Massachusetts, United States | ||
NAVX | $3M | 30 Dec 2006 | Ile-de-France | ||
EyeGate Pharmaceuticals | $10M | 02 Nov 2006 | Massachusetts, United States | ||
OctoPlus | $23M | 20 Jan 2005 | Leiden, South Holland, Netherlands | ||
CMC Biologics | $9M | 28 Dec 2004 | Copenhagen, Capital Region of Denmark, Denmark | ||
gate5 | $7M | 01 Mar 2004 | Berlin, Berlin, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
SpineGuard | $4M | 27 Sep 2011 | Ile-de-France | ||
Club Cooee | 27 Oct 2010 | Rhineland-Palatinate | |||
SpineGuard | $12M | 15 Sep 2009 | France, Ile-de-France, France | ||
EyeGate Pharmaceuticals | $15M | 12 Mar 2008 | Massachusetts, United States | ||
NAVX | $3M | 30 Dec 2006 | Ile-de-France | ||
EyeGate Pharmaceuticals | $10M | 02 Nov 2006 | Massachusetts, United States | ||
OctoPlus | $23M | 20 Jan 2005 | Leiden, South Holland, Netherlands | ||
CMC Biologics | $9M | 28 Dec 2004 | Copenhagen, Capital Region of Denmark, Denmark | ||
gate5 | $7M | 01 Mar 2004 | Berlin, Berlin, Germany |
